Five things for pharma marketers to know: Thursday, January 14, 2021
Johnson & Johnson to release COVID-19 vaccine trial data; Amgen pays $240 million for autoimmune therapy; Dollar General to pay employees to receive vaccine.
News
The Vaccine Project Newsletter: A shapeshifting response to a shapeshifting pandemic
The Vaccine Project Newsletter for the week of January 11, 2020 is 2,097 words and will take you nine minutes to read.
Does Congressional control alter Biden’s health-policy calculus?
With Democrats now in control of the Senate, the administration may have opportunities to expand access and affordability.
The Escalator: Parexel appoints chief patient officer
Plus personnel moves at the Point of Care Communication Council, FCB Health New York and QBFox Healthcomm.
MM+M launches 2021 Agency 100
The annual definitive guide to the world of medical marketing agencies will be published in June.
Five things for pharma marketers to know: Wednesday, January 13, 2021
HHS to begin gathering data on hospital vaccinations; Intarcia Therapeutics loses funding from Luxin Venture Capital Group; House Democrats test positive for COVID in riot’s wake.
Brand Film Awards open for entries; Google’s Jeffrey Whipps named 2021 jury chair
Haymarket Media’s pharma and healthcare marketing title MM+M joins the party for the initiative’s sixth year celebrating the best in filmmaking on behalf of brands.
Telehealth, drug prices, vaccine rollout headline day 2 of JPMorgan Healthcare Conference
Execs from Pfizer, Sanofi and CVS Health shared company updates with the virtual throng.
Behavioral scientists propose fixes for the ailing vaccine rollout
Sacrificing equity for vaccine expediency is a bad idea, behavioral-science experts warn.
Five things for pharma marketers to know: Tuesday, January 12, 2021
Eli Lilly drug shows promise in slowing cognitive decline; Japan discovers another COVID strain; Valo Health raises $190 million to develop AI platform.
Want to read more?
Please login or register first to view this content.
